title: Allergen and Molecular Partners join forces to strike deals worth US$1.5 billion.
authors.forename: Hannah
authors.initials: H
authors.lastname: Coaker
mesh_terms: D017487:Ankyrins / Q000627:therapeutic use; D055808:Drug Discovery / Q000191:economics*; D005128:Eye Diseases / Q000188:drug therapy; D006801:Humans; D007391:International Cooperation; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D017487:Ankyrins; D011994:Recombinant Proteins